ScholarIQanswers from OpenAlex

Risks of Death and Stroke in Patients Undergoing Hemodialysis With New-Onset Atrial Fibrillation

PaperCitations, authors & open-access status

Risks of Death and Stroke in Patients Undergoing Hemodialysis With New-Onset Atrial Fibrillation is a paper indexed in ScholarIQ from OpenAlex.

How many citations does Risks of Death and Stroke in Patients Undergoing Hemodialysis With New-Onset Atrial Fibrillation have?

ScholarIQcitation count

Risks of Death and Stroke in Patients Undergoing Hemodialysis With New-Onset Atrial Fibrillation has 77 citations in the OpenAlex counts ScholarIQ stores.

When was Risks of Death and Stroke in Patients Undergoing Hemodialysis With New-Onset Atrial Fibrillation published?

ScholarIQyear

Risks of Death and Stroke in Patients Undergoing Hemodialysis With New-Onset Atrial Fibrillation has 2016 year in the ScholarIQ index.

What is the open-access status of Risks of Death and Stroke in Patients Undergoing Hemodialysis With New-Onset Atrial Fibrillation?

ScholarIQoa status

Risks of Death and Stroke in Patients Undergoing Hemodialysis With New-Onset Atrial Fibrillation has closed oa status in the ScholarIQ index.

What is the DOI of Risks of Death and Stroke in Patients Undergoing Hemodialysis With New-Onset Atrial Fibrillation?

ScholarIQdoi

The DOI for Risks of Death and Stroke in Patients Undergoing Hemodialysis With New-Onset Atrial Fibrillation is on the source record.

What is the PMID of Risks of Death and Stroke in Patients Undergoing Hemodialysis With New-Onset Atrial Fibrillation?

ScholarIQpmid

The PMID for Risks of Death and Stroke in Patients Undergoing Hemodialysis With New-Onset Atrial Fibrillation is on the source record.

What is the OpenAlex record for Risks of Death and Stroke in Patients Undergoing Hemodialysis With New-Onset Atrial Fibrillation?

ScholarIQopenalex

The OpenAlex for Risks of Death and Stroke in Patients Undergoing Hemodialysis With New-Onset Atrial Fibrillation is on the source record.

Related on ScholarIQ

470M+ articles · 14-day free trial